Anti-CD25 therapy impairs donor-specific Th1 and Th2 cytokine-producing peripheral blood cells after clinical heart transplantation. [electronic resource]
Producer: 20030429Description: 2942-3 p. digitalISSN:- 0041-1345
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Cytokines -- antagonists & inhibitors
- Daclizumab
- Dose-Response Relationship, Drug
- Heart Transplantation -- immunology
- Humans
- Immunoglobulin G -- therapeutic use
- Immunosuppressive Agents -- therapeutic use
- Interferon-gamma -- blood
- Lymphocyte Transfusion
- Placebos
- Receptors, Interleukin-2 -- immunology
- Th1 Cells -- drug effects
- Th2 Cells -- drug effects
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.